抗微生物敏感剂:守门员,以避免多药耐药细菌的发展
Hanfei Wang1, Yingying Yang1, Simeng Wang1
1National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
耐多药细菌需要新的抗菌策略. 本综述介绍了非自身抗微生物敏感剂 (NSAS),以恢复抗生素的有效性,指导未来的药物开发.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 细菌中抗生素耐药性的增加构成了全球健康的重大威胁.
- 开发新型抗生素是昂贵和耗时的,需要替代策略.
- "抗生素辅助剂"的概念被模糊地定义,阻碍了药物开发.
研究的目的:
- 确定"非自身抗微生物敏感剂" (NSAS) 的准确定义.
- 为了区分NSAS与更广泛且定义较少的"抗生素辅助剂"概念.
- 作为一种可行的抗菌策略,指导NSAS的开发和研究.
主要方法:
- 文献综述和概念分析.
- 讨论恢复细菌对抗生素敏感性的科学方法.
- 检查现有的NSAS源和作用机制.
主要成果:
- 提出一个明确的NSAS定义,将其与抗生素辅助剂区分开来.
- 讨论了各种科学方法来使细菌对抗生素重新敏感.
- 分析了现有的NSAS,它们的起源和作用模式.
结论:
- 无抗菌药物是一种有前途的间接抗菌策略,用于打击多药耐药性.
- 澄清NSAS概念有助于有针对性的药物开发和研究.
- 这一审查为推进针对耐药细菌的基于NSAS的疗法提供了一个框架.
更多相关视频
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
相关概念视频
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
